Pluristem Therapeutics Inc
PSTI
Get informed when a big investor buys or sells
+ FollowMarket Cap$40.85M
Close$
$2.11
111.1% upside
Current Fair Value
111.1% upsideUndervalued by 111.1% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $40.85 Million |
|---|---|
| Enterprise Value | $43.87 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-3.56 |
| Beta | 1.91 |
| Outstanding Shares | 10,054,803 |
Return
| Return on Equity | 54.77% |
|---|---|
| Return on Assets | -65.34% |
| Return on Invested Capital | 182.49% |
Valuation & Multiples
| P/E Ratio | -0.99 |
|---|---|
| PEG | 38.35 |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | 37.46 |
| Enterprise Value to EBIT | -1.46 |
| Enterprise Value to Net Income | -5 |
| Total Debt to Enterprise | 0.15 |
| Debt to Equity | -0.35 |
Revenue Sources
No data
Insider Trades
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Pluristem Therapeutics Inc
CEO: Yaky Yanay